PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
复制标题
PRR14是促进肺癌发生的PI3K途径的新型激活剂。
DOI:
10.1038/onc.2016.93
复制
发表时间:
2016-10-20
期刊:
影响因子:
8
通讯作者:
Yuan ZM
中科院分区:
文献类型:
--
作者:
Yang M;Lewinska M;Fan X;Zhu J;Yuan ZM
Chromosomal focal amplifications often cause an increase in gene copy number contributing to the pathogenesis of cancer. PRR14 overexpression is associated with recurrent locus amplification in lung cancer, and it correlates with a poor prognosis. We show that increased PRR14 expression promoted and reduced PRR14 expression impeded lung cancer cell proliferation. Interestingly, PRR14 cells were markedly enlarged in size and exhibited an elevated activity of PI3-kinase/Akt/m-TOR pathway, which was associated with a heightened sensitivity to the inhibitors of PI3K and mTOR. Biochemical analysis revealed that PRR14, as a proline-rich protein, binds to the Src homology 3 (SH3) domains of GRB2 resulting in PI3K activation. Significantly, 2 cancer patient-derived PRR14 mutants displayed considerably augmented GRB2-binding and enhanced ability of promoting cell proliferation. Together with the in vivo data demonstrating a strong tumor-promoting activity of PRR14 and the mutants, our work uncovered this proline-rich protein as a novel activator of the PI3K pathway that promoted tumorigenesis in lung cancer.
登录
查看更多内容
影响因子:
14.9
作者:
Kamburov A;Stelzl U;Lehrach H;Herwig R
通讯作者:
Herwig R
影响因子:
64.8
作者:
LI, N;BATZER, A;SCHLESSINGER, J
通讯作者:
SCHLESSINGER, J
影响因子:
56.9
作者:
MAIGNAN, S;GUILLOTEAU, JP;DUCRUIX, A
通讯作者:
DUCRUIX, A
影响因子:
3.7
作者:
Job B;Bernheim A;Beau-Faller M;Camilleri-Broët S;Girard P;Hofman P;Mazières J;Toujani S;Lacroix L;Laffaire J;Dessen P;Fouret P;LG Investigators
通讯作者:
LG Investigators
影响因子:
64.5
作者:
BOOKER, GW;GOUT, I;CAMPBELL, ID
通讯作者:
CAMPBELL, ID